Richard Smith, who served as an editor of the prestigious British
Medical Journal (BMJ) for 25 years before resigning in 2004, warns that a
bulk of the studies published in medical journals are pioneered by drug
companies. More often than not, these studies push the agenda of the
companies that launched them, procuring positive results that were
cunningly derived through industry sleight of hand.
